Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Diabetic Drugs Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Biguanides
1.2.3 Sulfonylureas
1.2.4 Meglitinides
1.2.5 Thiazolidinediones
1.2.6 Dipeptidyl Peptidase IV Inhibitors
1.2.7 α-Glucosidase Inhibitors
1.3 Market by Application
1.3.1 Global Anti-Diabetic Drugs Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Diabetic Drugs Market Perspective (2018-2034)
2.2 Anti-Diabetic Drugs Growth Trends by Region
2.2.1 Global Anti-Diabetic Drugs Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Anti-Diabetic Drugs Historic Market Size by Region (2018-2023)
2.2.3 Anti-Diabetic Drugs Forecasted Market Size by Region (2024-2034)
2.3 Anti-Diabetic Drugs Market Dynamics
2.3.1 Anti-Diabetic Drugs Industry Trends
2.3.2 Anti-Diabetic Drugs Market Drivers
2.3.3 Anti-Diabetic Drugs Market Challenges
2.3.4 Anti-Diabetic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Diabetic Drugs Players by Revenue
3.1.1 Global Top Anti-Diabetic Drugs Players by Revenue (2018-2023)
3.1.2 Global Anti-Diabetic Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Anti-Diabetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Diabetic Drugs Revenue
3.4 Global Anti-Diabetic Drugs Market Concentration Ratio
3.4.1 Global Anti-Diabetic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Diabetic Drugs Revenue in 2024
3.5 Anti-Diabetic Drugs Key Players Head office and Area Served
3.6 Key Players Anti-Diabetic Drugs Product Solution and Service
3.7 Date of Enter into Anti-Diabetic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Diabetic Drugs Breakdown Data by Type
4.1 Global Anti-Diabetic Drugs Historic Market Size by Type (2018-2023)
4.2 Global Anti-Diabetic Drugs Forecasted Market Size by Type (2024-2034)
5 Anti-Diabetic Drugs Breakdown Data by Application
5.1 Global Anti-Diabetic Drugs Historic Market Size by Application (2018-2023)
5.2 Global Anti-Diabetic Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Anti-Diabetic Drugs Market Size (2018-2034)
6.2 North America Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Anti-Diabetic Drugs Market Size by Country (2018-2023)
6.4 North America Anti-Diabetic Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Diabetic Drugs Market Size (2018-2034)
7.2 Europe Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Anti-Diabetic Drugs Market Size by Country (2018-2023)
7.4 Europe Anti-Diabetic Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Diabetic Drugs Market Size (2018-2034)
8.2 Asia-Pacific Anti-Diabetic Drugs Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-Diabetic Drugs Market Size (2018-2034)
9.2 Latin America Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Anti-Diabetic Drugs Market Size by Country (2018-2023)
9.4 Latin America Anti-Diabetic Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Diabetic Drugs Market Size (2018-2034)
10.2 Middle East & Africa Anti-Diabetic Drugs Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astra Zeneca
11.1.1 Astra Zeneca Company Detail
11.1.2 Astra Zeneca Business Overview
11.1.3 Astra Zeneca Anti-Diabetic Drugs Introduction
11.1.4 Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.1.5 Astra Zeneca Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Anti-Diabetic Drugs Introduction
11.2.4 Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Anti-Diabetic Drugs Introduction
11.3.4 Eli Lilly Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.3.5 Eli Lilly Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Anti-Diabetic Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Anti-Diabetic Drugs Introduction
11.5.4 Merck Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-Diabetic Drugs Introduction
11.6.4 Novartis Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Anti-Diabetic Drugs Introduction
11.7.4 Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.7.5 Novo Nordisk Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Anti-Diabetic Drugs Introduction
11.8.4 Sanofi Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Detail
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Anti-Diabetic Drugs Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2018-2023)
11.9.5 Teva Pharmaceutical Industries Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-Diabetic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Biguanides
Table 3. Key Players of Sulfonylureas
Table 4. Key Players of Meglitinides
Table 5. Key Players of Thiazolidinediones
Table 6. Key Players of Dipeptidyl Peptidase IV Inhibitors
Table 7. Key Players of α-Glucosidase Inhibitors
Table 8. Global Anti-Diabetic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 9. Global Anti-Diabetic Drugs Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 10. Global Anti-Diabetic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Anti-Diabetic Drugs Market Share by Region (2018-2023)
Table 12. Global Anti-Diabetic Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 13. Global Anti-Diabetic Drugs Market Share by Region (2024-2034)
Table 14. Anti-Diabetic Drugs Market Trends
Table 15. Anti-Diabetic Drugs Market Drivers
Table 16. Anti-Diabetic Drugs Market Challenges
Table 17. Anti-Diabetic Drugs Market Restraints
Table 18. Global Anti-Diabetic Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Anti-Diabetic Drugs Market Share by Players (2018-2023)
Table 20. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2024)
Table 21. Ranking of Global Top Anti-Diabetic Drugs Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Anti-Diabetic Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anti-Diabetic Drugs Product Solution and Service
Table 25. Date of Enter into Anti-Diabetic Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-Diabetic Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Anti-Diabetic Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Anti-Diabetic Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 30. Global Anti-Diabetic Drugs Revenue Market Share by Type (2024-2034)
Table 31. Global Anti-Diabetic Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Anti-Diabetic Drugs Revenue Market Share by Application (2018-2023)
Table 33. Global Anti-Diabetic Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 34. Global Anti-Diabetic Drugs Revenue Market Share by Application (2024-2034)
Table 35. North America Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Anti-Diabetic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 39. Europe Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Anti-Diabetic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 41. Asia-Pacific Anti-Diabetic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 42. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Anti-Diabetic Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 44. Latin America Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Latin America Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Anti-Diabetic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 47. Middle East & Africa Anti-Diabetic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 48. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Anti-Diabetic Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 50. Astra Zeneca Company Detail
Table 51. Astra Zeneca Business Overview
Table 52. Astra Zeneca Anti-Diabetic Drugs Product
Table 53. Astra Zeneca Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 54. Astra Zeneca Recent Development
Table 55. Boehringer Ingelheim Company Detail
Table 56. Boehringer Ingelheim Business Overview
Table 57. Boehringer Ingelheim Anti-Diabetic Drugs Product
Table 58. Boehringer Ingelheim Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 59. Boehringer Ingelheim Recent Development
Table 60. Eli Lilly Company Detail
Table 61. Eli Lilly Business Overview
Table 62. Eli Lilly Anti-Diabetic Drugs Product
Table 63. Eli Lilly Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 64. Eli Lilly Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Anti-Diabetic Drugs Product
Table 68. Johnson & Johnson Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Merck Company Detail
Table 71. Merck Business Overview
Table 72. Merck Anti-Diabetic Drugs Product
Table 73. Merck Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 74. Merck Recent Development
Table 75. Novartis Company Detail
Table 76. Novartis Business Overview
Table 77. Novartis Anti-Diabetic Drugs Product
Table 78. Novartis Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 79. Novartis Recent Development
Table 80. Novo Nordisk Company Detail
Table 81. Novo Nordisk Business Overview
Table 82. Novo Nordisk Anti-Diabetic Drugs Product
Table 83. Novo Nordisk Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 84. Novo Nordisk Recent Development
Table 85. Sanofi Company Detail
Table 86. Sanofi Business Overview
Table 87. Sanofi Anti-Diabetic Drugs Product
Table 88. Sanofi Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Teva Pharmaceutical Industries Company Detail
Table 91. Teva Pharmaceutical Industries Business Overview
Table 92. Teva Pharmaceutical Industries Anti-Diabetic Drugs Product
Table 93. Teva Pharmaceutical Industries Revenue in Anti-Diabetic Drugs Business (2018-2023) & (US$ Million)
Table 94. Teva Pharmaceutical Industries Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Diabetic Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Anti-Diabetic Drugs Market Share by Type: 2024 VS 2034
Figure 3. Biguanides Features
Figure 4. Sulfonylureas Features
Figure 5. Meglitinides Features
Figure 6. Thiazolidinediones Features
Figure 7. Dipeptidyl Peptidase IV Inhibitors Features
Figure 8. α-Glucosidase Inhibitors Features
Figure 9. Global Anti-Diabetic Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Anti-Diabetic Drugs Market Share by Application: 2024 VS 2034
Figure 11. Type I Diabetes Case Studies
Figure 12. Type II Diabetes Case Studies
Figure 13. Others Case Studies
Figure 14. Anti-Diabetic Drugs Report Years Considered
Figure 15. Global Anti-Diabetic Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 16. Global Anti-Diabetic Drugs Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Anti-Diabetic Drugs Market Share by Region: 2024 VS 2034
Figure 18. Global Anti-Diabetic Drugs Market Share by Players in 2024
Figure 19. Global Top Anti-Diabetic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Diabetic Drugs as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Anti-Diabetic Drugs Revenue in 2024
Figure 21. North America Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. North America Anti-Diabetic Drugs Market Share by Country (2018-2034)
Figure 23. United States Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Anti-Diabetic Drugs Market Share by Country (2018-2034)
Figure 27. Germany Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Anti-Diabetic Drugs Market Share by Region (2018-2034)
Figure 35. China Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Japan Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. South Korea Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Southeast Asia Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. India Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Australia Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Anti-Diabetic Drugs Market Share by Country (2018-2034)
Figure 43. Mexico Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Brazil Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Anti-Diabetic Drugs Market Share by Country (2018-2034)
Figure 47. Turkey Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Saudi Arabia Anti-Diabetic Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Astra Zeneca Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 51. Eli Lilly Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 55. Novo Nordisk Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 56. Sanofi Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 57. Teva Pharmaceutical Industries Revenue Growth Rate in Anti-Diabetic Drugs Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed